A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
Clinical trial NCT06026501 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06026501
- Sponsor
- Shanghai YingLi Pharmaceutical Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2027-08-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.